The cryopreservation for the in-vitro fertilization market is expected to register a valuation of US$ 461.4 million in 2023. The market is anticipated to rise to US$ 1,264.9 million by 2033. The market is likely to record a CAGR of 10.6% during the forecast period.
Cryopreservation, or freezing and storing biological samples, is an essential technique in the in-vitro fertilization (IVF) field. Here are a few of the driving factors that are fueling the market growth are:
Overall, the market is expected to grow in the coming years as more couples seek fertility treatments and technological advancements continue to improve success rates.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The popularity of cryopreservation for in-vitro fertilization (IVF) is increasing among patients for several reasons:
Overall, the growing popularity of cryopreservation for IVF can be attributed to its improved success rates, flexibility, cost-effectiveness, preservation of fertility, and ethical considerations.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 10.6% |
| Market Valuation (2023) | US$ 461.4 million |
| Market Valuation (2033) | US$ 1,264.9 million |
The increasing demand for IVF treatments, advancements in cryopreservation technology, and rising awareness about the benefits of cryopreservation.
The market has shown steady growth in recent years, and the trend is expected to continue in the coming years. However, it is important to note that the COVID-19 pandemic may have impacted the market performance in 2020 and beyond.
The market is estimated to capture a valuation of US$ 1,264.9 million during the forecast period. Historically, the market registered a valuation of US$ 415.9 million from 2017 to 2022.
Principal Consultant
In the global market, the product type category that highly influences the market is the cryopreservation media segment. Cryopreservation media are the solutions used to freeze and store biological samples, such as embryos, eggs, and sperm, in IVF procedures. The cryopreservation media is likely to capture a CAGR of 10.5% by 2033.
The cryopreservation media segment is expected to witness significant growth in the coming years. The increasing demand for IVF treatments, rising awareness about the benefits of cryopreservation, and technological advancements in cryopreservation media.
According to Future Market Insights report, the cryopreservation media segment to the increasing use of vitrification as a method of cryopreservation, which requires specialized media. Overall, the cryopreservation media segment is expected to be a key influencer in the global market due to its crucial role in the freezing and storing of biological samples. Historically, cryopreservation media registered a CAGR of 9.2% from 2018 to 2022.
The end-user category that dominates the global cryopreservation for the in-vitro fertilization market is fertility clinics. Fertility clinics are specialized healthcare facilities that offer infertility treatments, including IVF procedures, to couples having difficulty conceiving. The IVF & fertility clinics are expected to capture a CAGR of 9.9% by 2033.
The fertility clinics segment is expected to continue to lead the market share globally. The increasing prevalence of infertility and the availability of advanced fertility treatments in developed countries as key drivers of the segment's growth. Historically, IVF & fertility clinics registered a CAGR of 8.6% from 2018 to 2022.
The United States has been one of the leading markets for cryopreservation in-vitro fertilization (IVF) services. According to a report by Future Market Insights, the United States is likely to thrive at a CAGR of 11.2% with a valuation of US$ 182.7 million by 2033.
The report attributes the strong performance of the United States market to several factors, including:
Overall, the increasing demand for fertility treatments and the availability of advanced healthcare infrastructure and technologies driving the market in the United States. Historically, the United States cryopreservation for the in-vitro fertilization market secured a CAGR of 9.9% between 2018 and 2022.
Germany has been a significant market for cryopreservation in-vitro fertilization (IVF) services. According to a report by Future Market Insights, Germany is expected to be one of the fast-growing markets in Europe during the forecast period. Germany is securing a CAGR of 11.6% with a valuation of US$ 54.8 million by 2033.
Germany is known for its advanced healthcare infrastructure and is one of the leading countries in Europe regarding reproductive medicine. It has led to a thriving cryopreservation market for in-vitro fertilization (IVF) in Germany.
Cryopreservation is freezing and storing eggs, sperm, or embryos for later use in IVF. This technology has revolutionized the field of reproductive medicine, allowing couples to conceive even after years of infertility.
Germany has some of the most advanced IVF clinics in Europe, offering cutting-edge cryopreservation technologies. These clinics use state-of-the-art equipment and techniques to freeze and store eggs, sperm, and embryos, which can be used for IVF later.
Germany has a well-established legal framework that regulates IVF and cryopreservation. It gives patients confidence that the highest ethical and safety standards handle frozen eggs, sperm, or embryos.
Overall, Germany is expected to continue to be driven by the increasing demand for fertility treatments and supportive government policies. Historically, Germany cryopreservation for in-vitro fertilization market secured a CAGR of 10.1% between 2018 and 2022.
The United Kingdom is significantly growing the global market by capturing a CAGR of 11.0% with a valuation of US$ 37 million by 2033. Growing healthcare infrastructure and strong research and development activities drive the United States cryopreservation for in-vitro fertilization market. While marketers play a role in promoting the benefits of cryopreservation, they are not the primary drivers of the market.
IVF clinics and healthcare providers in the United Kingdom are at the forefront of promoting cryopreservation as a viable option for couples who face fertility issues. These clinics offer advanced cryopreservation techniques and equipment, which have greatly improved the success rates of IVF procedures.
The United Kingdom has a strong research and development culture, with many universities and research institutions working on developing new technologies and techniques in the field of reproductive medicine. It has helped to advance the cryopreservation field, making it more accessible and effective for couples seeking IVF treatment.
While marketers may promote the benefits of cryopreservation through various channels, such as social media and advertising campaigns. The decision to undergo IVF treatment and cryopreservation ultimately lies with the patients and their healthcare providers.
The success of the cryopreservation market in the United Kingdom is primarily driven by the availability of advanced healthcare infrastructure and a supportive legal framework. Historically, the United States secured a CAGR of 9.7% between 2018 and 2022.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The cryopreservation for in-vitro fertilization (IVF) market is highly competitive and fragmented, with several players operating globally. The prominent players are focusing on providing services per patients' requirements through their research and development activities. Moreover, the market players adopt strategic plans for uplifting the market through partnerships, mergers, and acquisitions.
Other Prominent Players in the Cryopreservation for in-vitro fertilization Market are:
Recent Developments in the Global Cryopreservation for In-vitro Fertilization Market are:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Türkiye, Northern Africa, and South Africa |
| Key Segments Covered | Product, End User, Region |
| Key Companies Profiled | Thermo Fisher Scientific Inc.; Merck KGaA; VWR International, LLC; Avantor, Inc.; Charter Medical Ltd.; BioLife Solutions, Inc.; Cesca Therapeutics Inc.; Worthington Industries, Inc.; Taylor-Wharton International LLC |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
In 2023, the global demand for cryopreservation for IVF could generate US$ 461.4 million in revenue.
The global adoption of IVF cryopreservation is poised to witness a 10.6% CAGR through 2033.
The cryopreservation media segment garners higher revenue and is poised to have a 10.5% CAGR until 2033.
The regional market is expected to reach US$ 182.7 million by 2033 following an 11.2% CAGR till then.
The overall demand in Europe is poised to be driven by Germany with an 11.6% CAGR through 2033.
1. Executive Summary | Cryopreservation for In-vitro Fertilization (IVF) Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Cryopreservation Media
5.3.2. Cryopreservation Storage Devices
5.3.2.1. Dewars
5.3.2.2. Cryogenic Liquid Cylinders
5.3.2.3. Cryogenic Storage Tanks
5.3.2.4. Storage Container
5.3.3. Consumables & Accessories
5.3.3.1. Vitrification Carriers
5.3.3.2. Sperm Straws
5.3.3.3. Saw Freeze Straws
5.3.3.4. Cryovials
5.3.4. Cryo-Shipping
5.3.4.1. Dry Shipper Container
5.3.4.2. Clinical Pack Over Wrap
5.3.4.3. Cryogenic Labels
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Oocycte Cryopreservation
6.3.2. Sperm Cryopreservation
6.3.3. Embryo Cryopreservation
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033
7.3.1. Biobanks
7.3.2. IVF & Fertility Clinics
7.3.3. Research & Academic Institutes
7.3.4. Cryo-shipping/couriers
7.3.5. Cryo Monitoring /Inventory Management
7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. United Kingdom
11.2.1.2. Spain
11.2.1.3. Germany
11.2.1.4. Italy
11.2.1.5. France
11.2.1.6. Rest of Europe
11.2.2. By Product Type
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Indonesia
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Product Type
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product Type
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Type
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. South Africa
15.2.1.2. GCC Countries
15.2.1.3. Rest of Middle East and Africa
15.2.2. By Product Type
15.2.3. By Application
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Application
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Application
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Application
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Application
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Application
16.4.2.3. By End User
16.5. United Kingdom
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Application
16.5.2.3. By End User
16.6. Spain
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Application
16.6.2.3. By End User
16.7. Germany
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Application
16.7.2.3. By End User
16.8. Italy
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Application
16.8.2.3. By End User
16.9. France
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Application
16.9.2.3. By End User
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Application
16.10.2.3. By End User
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Application
16.11.2.3. By End User
16.12. Indonesia
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Application
16.12.2.3. By End User
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Application
16.13.2.3. By End User
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Application
16.14.2.3. By End User
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Application
16.15.2.3. By End User
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Application
16.16.2.3. By End User
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Application
16.17.2.3. By End User
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Application
16.18.2.3. By End User
16.19. South Africa
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Application
16.19.2.3. By End User
16.20. GCC Countries
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product Type
16.20.2.2. By Application
16.20.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Application
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Thermo Fisher Scientific Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Millipore Sigma
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. FUJIFILM Irvine Scientific
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Vitrolife AB
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. KITAZATO CORPORATION
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Brooks Life Sciences
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Corning Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Worthington Industries Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Cook Medical LLC
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Bio-Math Tech Ltd
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Cryo Solutions B.V.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. Cryogatt Systems Ltd.
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Cryopreservation for In-vitro Fertilization (IVF) Market
